{"DataElement":{"publicId":"2548499","version":"1","preferredName":"Gleason Score Primary Pattern Text","preferredDefinition":"The text field used to indicate the primary grade is the predominant pattern and the secondary grade is the secondary pattern (examples 2+3, 3+2, etc).","longName":"GLSN_SC_PRM _PATT_TXT","context":"DCP","contextVersion":"1","DataElementConcept":{"publicId":"2009221","version":"4","preferredName":"Gleason Score Pattern","preferredDefinition":"the resulting pattern for pathology of a specimen reported using the Gleason Score.","longName":"GLEASONSC_PATT","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2177083","version":"1","preferredName":"Gleason Score","preferredDefinition":"A system of grading prostate cancer cells to determine the best treatment and to predict how well a person is likely to do. A low Gleason score means the cancer cells are very similar to normal prostate cells; a high Gleason score means the cancer cells are very different from normal. ","longName":"Gleason Score","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Gleason Score for Prostate Cancer","conceptCode":"C28084","definition":"The score derived from universally embraced prostate cancer grading system developed by Dr. Donald F. Gleason in 1977. The system provides a reproducible description of the glandular architecture of prostate tissue to which a pathologist assigns a score depending primarily on the microscopic patterns of cancerous glands and cell morphology. The system correlates well with behavior at the extremes: Gleason 1+1 tumors are the most well differentiated, slowly growing and rarely spread; Gleason 4+5 tumors are the most poorly differentiated, often widely metastatic at the time of diagnosis. In the commoner intermediate grade tumors, however, behavior is extremely variable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACAAECCE-7A69-657B-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177442","version":"1","preferredName":"Pattern","preferredDefinition":"Pattern; anything characterized by repetition.","longName":"Pattern","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Pattern","conceptCode":"C25336","definition":"An arrangement of objects, facts, behaviors, or other things which have scientific, mathematical, geometric, statistical, or other meaning.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-5254-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DAA4910F-4B7C-524D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-17","endDate":null,"createdBy":"PWEST","dateCreated":"2004-05-17","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"updated for ISO compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2548497","version":"1","preferredName":"Gleason Score Primary Pattern Text","preferredDefinition":"The text field used for indicating the most frequent pattern or pathologic grade for s specimen or groups of specimens as interpreted by a pathologist using the Gleason Score scale.","longName":"GLSN_SC_PRM_PATT_TXT","context":"DCP","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2548496","version":"1","preferredName":"Gleason Score Primary Pattern Text","preferredDefinition":"A system of grading prostate cancer cells to determine the best treatment and to predict how well a person is likely to do. A low Gleason score means the cancer cells are very similar to normal prostate cells; a high Gleason score means the cancer cells are very different from normal. :Occurring first in time or sequence; original. (American Heritage Dictionary):Pattern; anything characterized by repetition.:Text; the words of something written.","longName":"C28084:C25251:C25336:C25704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gleason Score for Prostate Cancer","conceptCode":"C28084","definition":"The score derived from universally embraced prostate cancer grading system developed by Dr. Donald F. Gleason in 1977. The system provides a reproducible description of the glandular architecture of prostate tissue to which a pathologist assigns a score depending primarily on the microscopic patterns of cancerous glands and cell morphology. The system correlates well with behavior at the extremes: Gleason 1+1 tumors are the most well differentiated, slowly growing and rarely spread; Gleason 4+5 tumors are the most poorly differentiated, often widely metastatic at the time of diagnosis. In the commoner intermediate grade tumors, however, behavior is extremely variable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Primary","conceptCode":"C25251","definition":"Occurring first in time or sequence; original; of greatest rank or importance or value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Pattern","conceptCode":"C25336","definition":"An arrangement of objects, facts, behaviors, or other things which have scientific, mathematical, geometric, statistical, or other meaning.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Text","conceptCode":"C25704","definition":"The words of something written.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"23CA41B6-1052-1E55-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-12-04","modifiedBy":"ONEDATA","dateModified":"2006-12-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"23CA41B6-1063-1E55-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-12-04","modifiedBy":"MAESKEB","dateModified":"2007-03-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2194255","version":"1","longName":"Type of Condition","context":"DCP","ClassificationSchemeItems":[{"publicId":"2812182","version":"1","longName":"Tissue Effect of Finasteride - Prostate Cancer","context":"DCP"}]},{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044924","version":"1","longName":"Inactive CDEs as of March 2017","context":"NCIP"}]},{"publicId":"3896529","version":"1","longName":"Consortia 2012 Studies","context":"DCP","ClassificationSchemeItems":[{"publicId":"4528055","version":"1","longName":"UAZ2014-03-01","context":"DCP"}]}],"AlternateNames":[{"name":"caBIG","type":"USED_BY","context":"NCIP"}],"ReferenceDocuments":[{"name":"Gleason Grades","type":"Preferred Question Text","description":"Gleason Grades","url":null,"context":"DCP"},{"name":"Gleason Score for the Specimen Being Submitted for TCGA","type":"Alternate Question Text","description":"Gleason Score for the Specimen Being Submitted for TCGA","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"23CA490F-06FF-1F57-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-12-04","modifiedBy":"MAESKEB","dateModified":"2022-03-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}